Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CAMK2A | Q9UQM7 | 3/20 | 0.73 |
| ▸ | FFAR1 | O14842 | 6/20 | 0.52 |
| ▸ | POLB | P06746 | 1/20 | 0.50 |
| ▸ | FFAR4 | Q5NUL3 | 4/20 | 0.48 |
| ▸ | PTGER1 | P34995 | 1/20 | 0.46 |
| ▸ | PTGER4 | P35408 | 1/20 | 0.46 |
| ▸ | PTGER3 | P43115 | 1/20 | 0.46 |
| ▸ | PTGER2 | P43116 | 1/20 | 0.46 |
| ▸ | PCNA | P12004 | 1/20 | 0.46 |
| ▸ | SRD5A2 | P31213 | 1/20 | 0.46 |
| ▸ | PPARG | P37231 | 1/20 | 0.44 |
| ▸ | PPARD | Q03181 | 1/20 | 0.44 |
| ▸ | PPARA | Q07869 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2349799 | 0.93 | CAMK2A (0.71) | CAMK2AFFAR1FFAR4PTGER1PTGER4 | |
| SCHEMBL2353793 | 0.84 | CAMK2A (1.00) | CAMK2A | |
| SCHEMBL15434176 | 0.84 | PTGER4 (0.52) | CAMK2AFFAR1FFAR4PTGER1PTGER4 | |
| SCHEMBL3424972 | 0.83 | FFAR1 (0.64) | CAMK2AFFAR1POLBFFAR4PCNA | |
| SCHEMBL3503975 | 0.82 | FFAR1 (0.67) | CAMK2AFFAR1FFAR4PTGER1PTGER4 | |
| SCHEMBL4841064 | 0.80 | POLB (0.62) | CAMK2AFFAR1POLB | |
| SCHEMBL1666514 | 0.79 | CAMK2A (0.60) | CAMK2APCNA | |
| SCHEMBL2349794 | 0.78 | FFAR1 (0.58) | CAMK2AFFAR1FFAR4PTGER1PTGER4 | |
| SCHEMBL5015511 | 0.77 | POLB (0.51) | CAMK2APOLB | |
| SCHEMBL1271016 | 0.77 | CAMK2A (0.57) | CAMK2AFFAR1FFAR4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8252887-B2 | Biocompatible polymers for medical devices | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) | 2012-08-28 | — | — | US | disclosed |
| US-20100234555-A1 | BIOCOMPATIBLE POLYMERS FOR MEDICAL DEVICES | RUTGERS, THE STATE UNIVERSITY (US) | 2010-09-16 | — | — | US | disclosed |
| WO-2010042918-A1 | BIOCOMPATIBLE POLYMERS FOR MEDICAL DEVICES | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) | 2010-04-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100234555-A1 | BIOCOMPATIBLE POLYMERS FOR MEDICAL DEVICES | ECPAS, PTGIR, RXFP1 | CAMK2A 3861/4885FFAR1 827/4885POLB 4143/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.